---
title: >-
  Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face,
  and Hand: a Cross Sectional Study from the TARGET-DERM AD Cohort.
description: >-
  Explore this publication on real-world evidence: Epidemiology and Burden of
  Atopic Dermatitis Involving the Head, Neck, Face, and Hand: a Cross Sectional…
date: '2021-01-01'
category: Publications
tags:
  - Care
  - Atopic Dermatitis (AD)
  - Health System Partner
  - Pharma Partner
  - Poster Presentation
  - R&D
  - RAD Conference
  - Dermatology
canonical_url: >-
  https://www.pedestalhealth.com/resources/publications/care/epidemiology-and-burden-of-atopic--2021-rad-conference/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: epidemiology-and-burden-of-atopic--2021-rad-conference
id: 4n5UKS5vARFHsFR4LtdJso
contentType: article
---

## Challenge

This is the RAD 2021 poster—the earliest presentation—of the head, neck, face, and hand AD burden findings that were subsequently published in manuscript form (Row 10) and presented at Fall Clinical 2022 (Row 35). First dissemination of the finding that difficult-to-treat site involvement affects 85% of moderate-to-severe AD patients.

## Solution

TARGET-DERM AD cohort cross-sectional analysis of difficult-to-treat AD site prevalence and HRQoL impact (POEM, DLQI/CDLQI) at RAD 2021.

## Impact

Initial conference dissemination of the difficult-to-treat site burden data at RAD 2021 established the evidence foundation for subsequent manuscript publication and multi-venue dissemination, directly informing AbbVie's body-site-specific label development strategy for AD therapies.

### [Breda Munoz](/people/breda-munoz/)

![Breda Munoz, PhD — Profile Photo](https://images.ctfassets.net/h4s3ip99qawo/3H1T2mfvSNFj6w9tulnreq/a74ae05fe53e400f176d4e9c617b8fb8/breda-munoz.jpg)

### [Julie M. Crawford](/people/julie-crawford/)